We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CT Lung Screening Cuts Cancer Mortality in Half

By MedImaging International staff writers
Posted on 06 May 2019
Print article
A new study suggests that computerized tomography (CT) lung cancer screening can reduce the risk of lung cancer mortality by 51%, compared to x-ray screening.

Researchers at Hitachi General Hospital (HGH; Hitachi City, Japan), the National Center for Global Health and Medicine (Tokyo, Japan), the University of Tsukuba (Ibaraki, Japan), evaluated data regarding 17,935 individuals (average age 59.1 years, 54.5% male, 55.1% non-smokers) who underwent CT lung screening, and 15,548 individuals (average age 61.6 years, 58% female, 67.8% nonsmokers) who underwent x-ray lung screening. The researchers compared lung cancer incidence rate, mortality rate, and all-cause mortality rate for both groups.

The results revealed that in the CT group, 273 cases of lung cancer (1.5%), 72 cases of lung cancer death (0.4%), and 885 cases of all-cause death (4.9%) were observed. On the other hand, in the x-ray group, 164 cases (1.1%) of lung cancer, 80 cases (0.5%) of lung cancer death and 1,188 cases (7.6%) of all-cause death were observed. Overall, CT screening was associated with a 23% greater incidence of lung cancer than x-ray screening, but a 51% decrease in lung cancer mortality. The risk of all-cause mortality was also lower in the CT group than in the x-ray group by a statistically significant degree. The study was published in the February 2019 issue of the Japanese Journal of Clinical Oncology.

“The larger lung cancer incidence in the CT group is likely a result of the improved capacity of CT over x-ray. The majority of lesions identified on CT were 20 mm or smaller in diameter, whereas most lesions of that size went undetected on x-ray until they grew for five to seven years after initial screening,” concluded lead author Takeshi Nawa, MD, of HGH, and colleagues. “These results are consistent with our previous chronological study that demonstrated a 24% reduction in the lung cancer mortality rate among residents in Hitachi city four to eight years after the introduction of CT screening.”

In Japan, low-dose computed tomography (LDCT) screening has been employed since the 1990s. But unlike other countries, examinees also include light smokers and non-smokers. As a result, a large number of stage I lung cancers are detected, and the survival rate is high. In Hitachi city itself, LDCT screening for employees, retirees, their spouses, and community dwellers aged 50 years or older was introduced in 1998, regardless of smoking status, as a part of comprehensive health checkups in 2001.

Related Links:
Hitachi General Hospital
National Center for Global Health and Medicine
University of Tsukuba


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Brachytherapy Planning System
Oncentra Brachy
New
Ultrasound Table
Powered Ultrasound Table-Flat Top

Print article
Radcal

Channels

MRI

view channel
Image: PET/MRI can accurately classify prostate cancer patients (Photo courtesy of 123RF)

PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients

The Prostate Imaging Reporting and Data System (PI-RADS) is a five-point scale to assess potential prostate cancer in MR images. PI-RADS category 3 which offers an unclear suggestion of clinically significant... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.